You are looking for

In 2023, the impact of Artificial Intelligence (AI), including Machine Learning, on our lives became evident. Now is the right time to guide use of this pure technology with a legal and ethical framework. We need to apply fair use of AI rules so that explainable AI-based technologies can also be used in clinical care […]

After a few calmer summer weeks, the legislative work on the European Health Data Space (EHDS) is back to running at full steam towards adopting new policy with the potential to reshape the landscape for medtech innovation. The proposed secondary use policies outlined by EHDS will allow medtech companies to accelerate the development of artificial […]

Antimicrobial resistance (AMR) is now on the political agenda like never before. The WHO has called AMR a ‘silent pandemic’. The issue has been discussed by the G7 and it is among the priorities highlighted in the mission letter sent by European Commission President Ursula von der Leyen to the Commissioner responsible for health, Stella […]

The past few years have seen a seismic shift in the entire healthcare landscape. The COVID-19 crisis required a new level of “always-on” and “right now” innovation to enable care to be delivered to the front lines, to all patients, and across geographies. As COVID-19 evolves from an acute crisis to a chronic issue with unpredictable ebbs and flows, the hyper-focused approach to innovation is more important than ever. The world now knows what we can do, even when conditions are less than optimal. Our focus on helping patients by getting the best evidence, tools, and support to clinicians demonstrated the power of collaboration, imagination and dedication. Moving forward, patients and healthcare partners will accept nothing less than that level of commitment to transform the future of health forever.

Policymakers spent years on agreeing on one of the most modern medtech rules in the world – this should not be undermined by revisions to horizontal legislation. As Brussels powers down for a short summer lull, I find myself in a reflective mode. The pandemic has transformed our lives – suffice to say that we […]

One of the strongest trends I have observed in healthcare over the past decade has been the growth of patient power. Patients are actively shaping their care like never before. In response, health systems and companies are increasingly focused on the outcomes and experiences that matter to patients. The voice of patients is also becoming […]

Bringing innovative medical technology to patients around the world is a priority for the medtech industry. This task often relies on a wide network of third-party intermediaries and distributors. While third parties provide valuable local knowledge, logistics and skills, it is important to appreciate that everyone working on behalf of medtech companies is bound by […]

Looking at the Medtech industry and their IT solutions, it’s obvious that many companies underestimate the power of their digital solutions. With a deteriorating commercial climate, it’s more important than ever to fully capture the value of digital solutions and ensure they’re properly monetized – either directly or indirectly. But how should companies go about […]

This year, GMTCC is fully part of the MedTech Forum. By joining forces to build synergies between the business and compliance communities, the industry is sending a clear message: compliance is part of the business! I have always been in favour of having the compliance officer seen as a true business partner. Indeed, compliance programmes […]